Cincinnati Children’s is conducting a research study, sometimes known as a clinical trial or clinical study, to help us evaluate if the study drug tenofovir DF is effective and safe in the treatment of hepatitis B virus in children 2 to 11 years old. We also hope to learn about how kids’ bodies handle the study drug.
Children 2 to 11 years old who have been diagnosed with chronic hepatitis B may be eligible to participate.
Being in the study may not help your child. However, your child will have close medical monitoring of his/her health condition. When we complete the study, we hope to know if the study drug tenofovir DF is effective in treating Hepatitis B in children 2 to 11 years old.
Possible serious risks and discomforts to the child will be discussed with parents or guardians as part of the consenting process.
Families may receive up to $1,200 for time and effort. If eligible, families may receive travel reimbursement.
Tracie Horning
513-636-7511
tracie.horning@cchmc.org
Gastroenterology, Hepatology & Nutrition
Cincinnati Children’s Hospital Medical Center, MLC
3333 Burnet Ave.
Cincinnati, OH 45229-3039
Jorge A. Bezerra, MD
Gastroenterology, Hepatology, & Nutrition
Cincinnati Children’s Hospital Medical Center